Cancer "-omics"
Identification of De Novo Enhancers Activated by TGFβ to Drive Expression of CDKN2A and B in HeLa Cells
Yen-Ting Liu, Lin Xu, Lynda Bennett, Jared C. Hooks, Jing Liu, Qinbo Zhou, Priscilla Liem, Yanbin Zheng and Stephen X. Skapek
Yen-Ting Liu
Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
Lin Xu
Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
Lynda Bennett
Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
Jared C. Hooks
Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
Jing Liu
Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
Qinbo Zhou
Quantitative Biomedical Research Center, Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
Priscilla Liem
Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
Yanbin Zheng
Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
Stephen X. Skapek
Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
DOI: 10.1158/1541-7786.MCR-19-0289 Published September 2019

This article requires a subscription to view the full text. You may purchase access to this article or login to access your subscription using the links below.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't.
September 2019
Volume 17, Issue 9
Volume 17, Issue 9
Identification of De Novo Enhancers Activated by TGFβ to Drive Expression of CDKN2A and B in HeLa Cells
Yen-Ting Liu, Lin Xu, Lynda Bennett, Jared C. Hooks, Jing Liu, Qinbo Zhou, Priscilla Liem, Yanbin Zheng and Stephen X. Skapek
Mol Cancer Res September 1 2019 (17) (9) 1854-1866; DOI: 10.1158/1541-7786.MCR-19-0289
Identification of De Novo Enhancers Activated by TGFβ to Drive Expression of CDKN2A and B in HeLa Cells
Yen-Ting Liu, Lin Xu, Lynda Bennett, Jared C. Hooks, Jing Liu, Qinbo Zhou, Priscilla Liem, Yanbin Zheng and Stephen X. Skapek
Mol Cancer Res September 1 2019 (17) (9) 1854-1866; DOI: 10.1158/1541-7786.MCR-19-0289
Jump to section
Advertisement